-
Galderma Laboratories LP et al v. Tolmar Inc. DC CAFC
- 1:10-cv-00045
- D. Del.
- Judge: Leonard P. Stark
- Filed: 01/21/2010
- Closed: 09/24/2012
- Latest Docket Entry: 06/14/2019
- PACER
3
Plaintiffs
2
Defendants
1
Accused
Product
5
Patents-in-Suit
978
Days in
Litigation
-
Galderma Laboratories LP et al v. Tolmar Inc. DC CAFC
- 1:10-cv-00045
- D. Del.
- Judge: Leonard P. Stark
- Filed: 01/21/2010
- Closed: 09/24/2012
- Latest Docket Entry: 06/14/2019
- PACER
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
24 |
The method according to claim 23, wherein said individual is afflicted with common acne.
|
Enforceable and Valid
Entry 340 |
27 |
The method according to claim 24, wherein the composition is a gel comprising adapalene, carbomer 940, disodium edentate, methyl paraben, poloxamer 124, propylene glycol, sodium hydroxide and purified water.
|
Enforceable and Valid
Entry 340 |
Claim # | Claim Text | Outcome |
---|---|---|
5 |
A topically applicable pharmaceutical composition comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) relative to the total weight of the composition, effective for the treatment of acne, formulated into a
view more
|
Enforceable and Valid
Entry 340 |
Claim # | Claim Text | Outcome |
---|---|---|
35 |
The topically applicable aqueous gel composition as defined by claim 1, wherein said aqueous gel medium comprises at least one carbomer.
|
Enforceable and Valid
Entry 340 |
36 |
The topically applicable aqueous gel composition as defined by claim 1, wherein said aqueous gel medium comprises carbomer 940.
|
Enforceable and Valid
Entry 340 |
Claim # | Claim Text | Outcome |
---|---|---|
2 |
A method for treating common acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a thus effective amount of a pharmaceutical composition which is a gel of:</claim-text>
|
Enforceable and Valid
Entry 340 |
3 |
The method according to claim 2, wherein the common acne is of moderate to moderately severe intensity.
|
Enforceable and Valid
Entry 340 |
-
Infringement
Tolmar Incorporated
- 5 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic 0.3% Adapalene gel Pursuant to ANDA No. 200298 | US 7,579,377 B2 |
2, 3
|
No infringement
Entry 340
|
Generic 0.3% Adapalene gel Pursuant to ANDA No. 200298 | US 7,737,181 B2 |
35, 36
|
Infringement
Entry 340
|
Generic 0.3% Adapalene gel Pursuant to ANDA No. 200298 | US 7,834,060 B2 |
24, 27
|
Infringement
Entry 340
|
Generic 0.3% Adapalene gel Pursuant to ANDA No. 200298 | US 7,838,558 B2 |
5
|
Infringement
Entry 340
|
Generic 0.3% Adapalene gel Pursuant to ANDA No. 200298 | US 7,868,044 B2 |
40, 41
|
Infringement
Entry 340
|